A phase II study of bryostatin 1 in metastatic malignant melanoma.

Bryostatin 1 is a protein kinase C partial agonist which has both antineoplastic and immune-stimulatory properties, including the induction of cytokine release and expansion of tumour-specific lymphocyte populations. In phase I studies, tumour responses have been observed in patients with malignant...

Descripción completa

Detalles Bibliográficos
Autores principales: Propper, D. J., Macaulay, V., O'Byrne, K. J., Braybrooke, J. P., Wilner, S. M., Ganesan, T. S., Talbot, D. C., Harris, A. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063191/
https://www.ncbi.nlm.nih.gov/pubmed/9823975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063191/
https://www.ncbi.nlm.nih.gov/pubmed/9823975

Ejemplares similares